Market Cap | 2.54M | P/E | 0.00 | EPS this Y | - | Ern Qtrly Grth | - |
Income | 6.14M | Forward P/E | - | EPS next Y | - | 50D Avg Chg | -24.00% |
Sales | 1.24M | PEG | - | EPS past 5Y | - | 200D Avg Chg | -17.00% |
Dividend | N/A | Price/Book | 0.00 | EPS next 5Y | - | 52W High Chg | -66.00% |
Recommedations | - | Quick Ratio | 0.01 | Shares Outstanding | 7.23B | 52W Low Chg | 38.00% |
Insider Own | - | ROA | 2.30% | Shares Float | - | Beta | 0.60 |
Inst Own | - | ROE | 54.62% | Shares Shorted/Prior | -/- | Price | 0.00055 |
Gross Margin | 80.00% | Profit Margin | 496.44% | Avg. Volume | 25,484,474 | Target Price | - |
Oper. Margin | 62.22% | Earnings Date | - | Volume | 1,840,631 | Change | 0.00% |
Global Roundtable Corporation operates in the health and wellness business. It also provides products and ancillary services in the mental wellness segment and optical-vision medical care. The company was formerly known as Green Cures & Botanical Distribution Inc. and changed its name to Global Roundtable Corporation in May 2023. Global Roundtable Corporation was incorporated in 1986 and is based in Denver, Colorado.